Award notice Supplies

Lieky ATC skupiny L04AB02, Infliximab parent. 100 mg

Notice published in Slovak. The AI analysis summarises it for you in your language.

Public buyer: Všeobecná zdravotná poisťovňa, a.s.
Bratislava - mestská časť Petržalka
Place of performance: Bratislava - mestská časť Petržalka
Estimated value: €2,667,150 excl. VAT
Amount awarded: €2,667,150 excl. VAT
Planned end of contract: 8 October 2029
likely re-tender around April 2029
Bids received: 4
Form: Framework agreement
Multi-year contract: the buyer places orders as needs arise.
Procedure: Open procedure
Any company may submit a bid.
Publication: 13 October 2026
Notice language: Slovak

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Unlimited analyses during the 14-day Pro trial, no card needed.

Lieky ATC skupiny L04AB02, Infliximab parent. 100 mg

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33652000

Contract	Winner	Amount
Imunoglobulíny Nemocnica Poprad, a.s. · 14 October 2026	MED - ART, spol. s r.o.	€185,129
Antiinfektíva III Národný ústav srdcových a cievnych chorôb, a.s. · 21 September 2026	MED - ART, spol. s r.o. INTRAVENA s.r.o.	€461,380
Všeobecné antiinfekčné látky na systémové použitie a očkovacie látky pre nemocničnú lekáreň Špecializovaná nemocnica sv. Svorada Zobor, n.o. · 12 August 2026	MED - ART, spol. s r.o.	€168,125
Daratumumab Fakultná nemocnica Trnava · 10 July 2026	UNIPHARMA - 1. slovenská lekárnická akciová spoločnosť	€1,009,800

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 705673-2026.